Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Express Scripts
Farmers Insurance

Generated: March 24, 2018

Patent: ➤ Try a Free Trial

Summary for Patent: ➤ Try a Free Trial

Title:Use of anti-CD19 maytansinoid immunoconjugate antibody for the treatment of B-cell malignancies symptoms
Abstract: An anti-CD19 maytansinoid immunoconjugate is used for treating B-cell malignancies symptom, in particular Non-Hodgkin\'s lymphoma.
Inventor(s): Morariu; Rodica (Paris, FR)
Assignee: Sanofi (Paris, FR)
Application Number:14/117,806
Patent Claim Types:
see list of patent claims
Use; Delivery;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
GenentechRITUXANrituximabVIAL1037050011997-11-26➤ Try a Free Trial Sanofi (Paris, FR) Morariu; Rodica (Paris, FR) ➤ Try a Free TrialRXsearch
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Summary for Patent: ➤ Try a Free Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
11290232May 17, 2011
PCT Information
PCT FiledMay 16, 2012PCT Application Number:PCT/EP2012/059141
PCT Publication Date:November 22, 2012PCT Publication Number: WO2012/156455

International Patent Family for Patent: ➤ Try a Free Trial

Country Document Number Publication Date
South Africa201309400Apr 29, 2015
World Intellectual Property Organization (WIPO)2012156455Nov 22, 2012
Uruguay34077Jan 03, 2013
United States of America2014072587Mar 13, 2014
United States of America2017196988Jul 13, 2017
Ukraine114401Jun 12, 2017
Taiwan201249460Dec 16, 2012
Taiwan201726167Aug 01, 2017
Tunisia2013000468Mar 30, 2015
Singapore10201609729VDec 29, 2016
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: